Avantor price target raised to $26 from $25 at Baird

Baird analyst Catherine Schulte raised the firm’s price target on Avantor to $26 from $25 and keeps an Outperform rating on the shares. The firm said 4Q results were ahead of their model, with upside across all geographic regions. as management noted improvements in customer inventory levels and bioprocessing order book, though stopped short of calling an order inflection.